Linking To, Excerpting From, And Embedding Dr. Nick Norwitz’ “Statins Slash GLP-1 Levels: Human Cointrolled Trial” With Links To Two Additional Resources

In addition to today’s resource, please review:

  • Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. Cell Metab. 2024 Feb 6;36(2):408-421.e5. doi: 10.1016/j.cmet.2023.12.027.

Today, I review, link to, excerpt from, and embed Dr. Nick Norwitz
Statins Slash GLP-1 Levels: Human Controlled Trial.

All that follows is from the above resource.

Human trial data published in a major journal show that statins cause insulin resistance and deplete GLP-1 levels in humans. This should have been breaking news! Why is no one talking about it? Why don’t doctors know? Why aren’t patients being informed about the risks?
For references and a written breakdown, see the StayCurious Metabolism Newsletter: https://open.substack.com/pub/staycur…
All Newsletters can be found at https://StayCuriousMetabolism.com
Chapters
0:00 – Statins Cause Insulin Resistance and Decrease GLP-1 1:18 – Why This Statin Paper Upset Me: A Hidden Health Crisis 2:05 – What Do a Dozen Doctors Think About Statins and GLP-1 2:40 – A Look at the Cell Metabolism Data: Statins, Insulin Resistance, and GLP-1
5:24 – Fecal Transplant: Revealing the Central Role of the Microbiome
6:06 – Mechanism Breakdown: How Statins Trigger Insulin Resistance and Lower GLP-1
6:34 – Human Trial with UDCA Supplementation Reverses Statin-Induced Metabolic Damage
7:10 – The Compass of Medicine: Prioritizing Profits Over Patient Health
9:07 – What the Heck? Available on Amazon? (NOT Medical Advice)
9:56 – Call To Action: Talk, Share, Force the Conversation

 

This entry was posted in GLP-1, Medical News, Statins, StatPearls. Bookmark the permalink.